The roar of the crowd, the crisp autumn air, the sizzle of the grill – for generations, these have been the indelible hallmarks of American football season.
And inextricably linked to this beloved ritual is the feast: platters piled high with greasy burgers, hot dogs dripping with condiments, mountains of chips, and rivers of sugary soda.
It’s a culinary tradition so entrenched that Super Bowl Sunday eclipses even Christmas and Easter in caloric consumption, and Thanksgiving, with its trio of NFL games, stands as our nation’s undisputed champion of overeating.
Week 1 tailgating, seemingly innocent, has long been our collective gateway to Gluttonyville.
But something is shifting on the sidelines, a quiet revolution brewing in our bellies and grocery carts.
The ascendance of GLP-1 weight-loss drugs like Ozempic and Wegovy is beginning to challenge this sacred union of food and football, redrawing the battle lines between indulgence and health, and sending ripples through the multi-billion-dollar snack industry.
Consider the data, a stark reflection of our ingrained habits: fans of losing football teams, perhaps drowning their sorrows, devour 16% more saturated fat the day after a big game.
Winning fans, conversely, consume 9% less.
Yet, even in victory, the sheer volume of our game-day eating remains staggering.
This deep-seated pattern is now confronting a potent new force.
Cornell University and market research firm Numerator reveal that within six months of starting GLP-1s, new users slash their overall grocery spending by an average of 6%.
More tellingly, they’re actively ditching the ultra-processed mainstays of tailgating – the chips, the sugary drinks, even the classic hot dogs and hamburgers – in favor of healthier alternatives. Consider checking out this list of healthier tailgating food options.
This isn’t just a personal choice; it’s a seismic tremor for retailers.
Amanda Mosseri Oren, Vice President of Industry Strategy for Relex Solutions, a firm specializing in supply chain logistics, notes that grocers are already “adapting their strategies accordingly.”
The days of endless salty snack promotions dominating end caps might not be entirely over in a country where 40% of the population grapples with obesity, but a subtle evolution is underway.
Expect to see more celery sticks and hummus alongside the potato chip bags as GLP-1 users reshape purchase orders.
Grocers are even “reformulating ready-meal offerings to include higher protein content and more vegetables,” recognizing that the traditional convenience food playbook no longer aligns with evolving consumer needs. For more on these trends, refer to the U.S. Grocery Shopper Trends report.
For retailers already catering to the health-conscious, this trend presents a golden opportunity, potentially expanding their customer base to individuals with more disposable income.
However, like any significant societal shift, there’s a nuanced wrinkle.
The research also highlights a disproportionate impact: higher-income households, those who can more readily afford the monthly cost of these drugs, are cutting their shopping by nearly 9%.
This trend, consistent since 2024, is only strengthening.
It paints a picture where the affluent are not only getting thinner but also saving money, creating a conundrum for the wealthy titans of the junk food industry who thrive on our collective cravings.
For the vast majority, the prohibitive cost of GLP-1s remains a significant barrier, preventing a large-scale shift without greater insurance coverage, subsidies, or a more competitive market to drive prices down.
Yet, even for those on the drugs, human nature persists.
Brandon McFadden, a professor at the University of Arkansas specializing in food policy economics, offers a fascinating insight: GLP-1 users still crave ultra-processed snacks.
The difference, he explains, is that “they just don’t want to pig out anymore.”
The drugs appear to reduce stomach size and overall calorie intake, but the desire for that salty crunch or sweet hit doesn’t vanish entirely.
It’s a testament to the complex interplay of physiology and psychology that governs our eating habits.
And with new, even more potent drugs in development, capable of achieving up to 24% weight reduction in 36 weeks, the landscape is poised for further dramatic transformation.
Beyond the pharmaceutical intervention, a broader awakening is taking hold.
Sally Lyons Wyatt, global executive vice president and chief advisor for consumer goods and food service insights at Circana, reports a stunning statistic: 60% of U.S. consumers now actively read food labels. For comprehensive insights, check out Understanding Food Labels from Harvard’s Nutrition Source.
“I can guarantee you that was not the case five years ago, not even close,” she quips.
This heightened awareness, catalyzed in part by the pandemic and a renewed focus on personal well-being, means more people are scrutinizing what they put into their bodies.
So, as the football season unfolds, we find ourselves at a fascinating crossroads.
The deep-seated traditions of American indulgence are meeting the undeniable force of scientific innovation and a growing collective consciousness about health.
While indulgence, as Wyatt wisely notes, is inherently human and will never truly disappear, we may be witnessing the dawn of an era defined by greater moderation.
Perhaps, even if your team endures a winless season and the urge to stress-eat is overwhelming, a conscious effort to balance those moments of weakness with healthier choices the rest of the week might just ensure you can still fit into your favorite jersey come playoff time.
The game, it seems, is changing, both on and off the field.
